|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300072282 |
|
最近更新日期: Date of Last Refreshed on: |
2023-06-08 16:04:51 |
|
注册时间: Date of Registration: |
2023-06-08 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
VR技术在地震救援及灾后重建护士培训中的临床试验研究 |
|
Public title: |
Clinical trial of VR technology in the training of nurses in earthquake rescue and post-disaster reconstruction |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
虚拟现实技术在地震救援及灾后重建护士培训中的探索性研究 |
|
Scientific title: |
Exploratory study of virtual reality technology in the training of earthquake rescue and post-disaster reconstruction nurses |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
罗文 |
研究负责人: |
赵慧雯 |
|
Applicant: |
Luo Wen |
Study leader: |
Zhao Huiwen |
|
申请注册联系人电话: Applicant telephone: |
+86 131 1619 0054 |
研究负责人电话:
Study leader's |
+86 139 2013 6861 |
|
申请注册联系人传真 : Applicant Fax: |
60910201 |
研究负责人传真: Study leader's fax: |
60910201 |
|
申请注册联系人电子邮件: Applicant E-mail: |
wl1984@yhaoo.com |
研究负责人电子邮件: Study leader's E-mail: |
zhaohuiwen1968@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
天津市河西区解放南路406号 |
研究负责人通讯地址: |
天津市河西区解放南路406号 |
|
Applicant address: |
No.406. Jiefangnan Rd, Hexi District,Tianjin |
Study leader's address: |
No.406.Jiefangnan Rd,Hexi District, |
|
申请注册联系人邮政编码: Applicant postcode: |
300211 |
研究负责人邮政编码: Study leader's postcode: |
300211 |
|
申请人所在单位: |
天津市天津医院 |
||
|
Applicant's institution: |
Tianjin Hospital |
||
|
研究负责人所在单位: |
天津市天津医院 |
||
|
Affiliation of the Leader: |
Tianjin Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023-YLS-003 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
天津市天津医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Tianjin Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-02-23 00:00:00 | ||
|
伦理委员会联系人: |
戴滨 |
||
|
Contact Name of the ethic committee: |
Dai Bin |
||
|
伦理委员会联系地址: |
天津市河西区解放南路406号 |
||
|
Contact Address of the ethic committee: |
No.406,Jiefangnan Rd, Hexi District, Tianjin Hospital |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 138 2166 0135 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
天津市天津医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Tianjin Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
天津市河西区解放南路406号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.406,Jiefangnan Rd, Hexi District, Tianjin Hospital |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
天津市护理学会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Tianjin Nursing Association |
||||||||||||||||||||||
|
研究疾病: |
临床护理教育 |
||||||||||||||||||||||
|
Target disease: |
Clinical Nursing Education |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
通过虚拟现实技术,开发地震灾害救援3D模拟救援训练系统,此种方式与临床护理教育相结合,让临床护士在熟悉地震灾害救援及灾后重建过程中能够快速进入角色,达到教学培训目的,为虚拟现实技术在护理教育中的应用提供有效途径。 |
||||||||||||||||||||||
|
Objectives of Study: |
Through virtual reality technology, the 3D simulation rescue training system for earthquake disaster rescue is developed. This method is combined with clinical nursing education, so that clinical nurses can quickly enter the role in the process of familiarizing themselves with earthquake disaster rescue and post-disaster reconstruction, to achieve the purpose of teaching and training, and to provide an effective way for the application of virtual reality technology in nursing education. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)取得护士职业资格证书,长期从事临床护理工作;(2)工作年限5年以上,年龄≤50岁;(3)不存在眩晕症等VR训练禁忌证。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Obtained the professional qualification certificate of nurse and engaged in clinical nursing for a long time; (2) Working experience of more than 5 years, age ≤ 50 years; (3) There is no contraindication of VR training such as vertigo. |
||||||||||||||||||||||
|
排除标准: |
(1)视力不佳,双眼矫正视力1.0以下的护士(E视力表);(2)长期患有心脏病、高血压等慢性疾病。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Nurses with poor vision and binocular corrected vision less than 1.0 (E vision chart); (2) Chronic diseases such as heart disease, hypertension, etc. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-01-01 00:00:00至 To 2024-07-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-07-01 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究者将纳入本研究的护士依次进行编号,再由两名未参与编号独立研究人员运用随机数字表生成器,生成1—160的随机号码表,在随机号码表上任意规定抽样的起点和抽样的顺序,依次从随机号码表上抽取样本号码,根据随机抽取的样本号码进行分组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The researchers numbered the nurses who were included in the study in turn, and then two independent researchers who did not participate in the numbering used the random number table generator to generate a random number table of 1-160. The starting point and sequence of sampling were randomly specified |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
No shareing raw data |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
在数据收集过程中,首先调查人员向研究对象解释研究目的、权利、义务和其他注意事项,并获得了研究对象的知情同意。调查人员使用统一的指导语言向研究对象解释了问卷的要求。在调查过程中,研究对象的隐私受到保护,所有问卷都在填写完成时收集。 收集好的问卷资料再由另外两名研究成员独立录入ResMan临床试验公共管理平台。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
In the process of data collection, the investigator first explained the research purpose, rights, obligations and other considerations to the research object, and obtained the informed consent of the research object. The investigators explained the requirements of the questionnaire to the subjects in a unified guidance language. During the survey, the privacy of the subjects was protected, and all questionnaires were collected when they were completed. The collected questionnaire data will be independently entered into the ResMan clinical trial public management platform by two other research members. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |